Drug
Surgilube
Surgilube is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_4
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Completed1
Not yet recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
completed133%
not_yet_recruiting133%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
NCT06960317
not_yet_recruitingnot_applicable
Empathy Through Pain Control: Lidocaine Gel vs. Placebo Prior to IUD Placement
NCT06974032
completedphase_4
Lidocaine Jelly for Pain Control During Mohs Surgery
NCT03595449
Clinical Trials (3)
Showing 3 of 3 trials
NCT06960317Not Applicable
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
NCT06974032Not Applicable
Empathy Through Pain Control: Lidocaine Gel vs. Placebo Prior to IUD Placement
NCT03595449Phase 4
Lidocaine Jelly for Pain Control During Mohs Surgery
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3